EPIGET EPIRUBICIN INJECTION

Get a Price/Quote

EPIGET EPIRUBICIN INJECTION Specification

Dosage Form
Parenteral (Injection)

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Epirubicin hydrochloride

Origin of Medicine
Synthetic

Indication
Breast cancer, ovarian cancer, gastric cancer, lung cancer, lymphomas

Drug Type
Prescription

Ingredients
Epirubicin hydrochloride

Physical Form
Injection

Function

Recommended For
Treatment of breast cancer and other malignancies

Dosage
As prescribed by physician, typically 60-100 mg/m intravenously

Dosage Guidelines
Strictly follow medical advice, administered under supervision

Suitable For
Adults

Quantity
Available in 10 mg/5 ml and 50 mg/25 ml vials

Storage Instructions
Store below 25C, protect from light

EPIGET EPIRUBICIN INJECTION Trade Information

Packaging Details
PACK IN FORM OF VIAL

About EPIGET EPIRUBICIN INJECTION

Epiget Injection

Specifications : -

Brand Name : EPIGET
Content : Epirubicin
Strength : 50 Mg and 10 Mg
Form : Injection
Packing : Pack in form of vial
Manufactured By :GLS

Note: - EPIGETIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Therapeutic Indications and Benefits

EPIGET EPIRUBICIN INJECTION is recommended for adults in the treatment of various cancers such as breast, ovarian, gastric, and lung cancer as well as lymphomas. As a chemotherapy agent, it helps reduce or eliminate cancerous cells, supporting treatment objectives tailored by oncology specialists.

Route of Administration and Dosage Guidelines

This medication is administered exclusively as an intravenous injection by healthcare professionals. The recommended dosage typically ranges from 60-100 mg/m, depending on the patients condition and physicians assessment. Strict adherence to prescribed dosage and administration guidelines ensures effectiveness and safety for the patient.

Safety, Precautions, and Monitoring

Due to potential side effects including nausea, anemia, neutropenia, alopecia, and cardiac toxicity, careful monitoring of cardiac function and regular assessment of blood counts are essential during treatment. EPIGET EPIRUBICIN is unsuitable for pregnant women, patients with severe hepatic impairment, or significant bone marrow suppression.

FAQs of EPIGET EPIRUBICIN INJECTION:

Q: How is EPIGET EPIRUBICIN INJECTION administered to patients?

A: EPIGET EPIRUBICIN INJECTION is given intravenously, meaning it is injected directly into the vein. The administration must be carried out by a qualified healthcare professional in a clinical setting to ensure proper dosing and monitoring.

Q: What conditions is this injection typically used to treat?

A: EPIGET EPIRUBICIN INJECTION is primarily prescribed for the treatment of breast cancer, but it is also indicated for ovarian cancer, gastric cancer, lung cancer, and lymphomas as part of a comprehensive chemotherapy regimen.

Q: When should EPIGET EPIRUBICIN INJECTION not be used?

A: This medication is contraindicated in patients who are pregnant, have severe hepatic impairment, or suffer from significant bone marrow suppression. It is vital to inform your doctor of your medical history prior to treatment.

Q: Where should EPIGET EPIRUBICIN INJECTION be stored before use?

A: The injection should be stored below 25C and kept protected from light. Always store the product in its original packaging to ensure its stability and effectiveness.

Q: What are the key precautions during the use of this injection?

A: Patients must have their cardiac function and blood counts regularly assessed during treatment due to the risk of cardiac toxicity and blood-related side effects. Treatment should always be carried out under close medical supervision.

Q: How does EPIGET EPIRUBICIN benefit cancer patients?

A: As an antineoplastic agent, EPIGET EPIRUBICIN works by interfering with the growth of cancer cells, helping to shrink tumors and control the spread of malignancies, ultimately supporting improved treatment outcomes.

Tell us about your requirement